BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 14616825)

  • 1. Etanercept-induced systemic lupus erythematosus.
    Swale VJ; Perrett CM; Denton CP; Black CM; Rustin MH
    Clin Exp Dermatol; 2003 Nov; 28(6):604-7. PubMed ID: 14616825
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Etanercept-induced systemic lupus erythematosus in a patient with rheumatoid arthritis.
    Kang MJ; Lee YH; Lee J
    J Korean Med Sci; 2006 Oct; 21(5):946-9. PubMed ID: 17043436
    [TBL] [Abstract][Full Text] [Related]  

  • 3. TNF alpha antagonist-induced lupus-like syndrome: report and review of the literature with implications for treatment with alternative TNF alpha antagonists.
    Williams VL; Cohen PR
    Int J Dermatol; 2011 May; 50(5):619-25. PubMed ID: 21506984
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Drug-induced systemic lupus erythematosus associated with etanercept therapy.
    Shakoor N; Michalska M; Harris CA; Block JA
    Lancet; 2002 Feb; 359(9306):579-80. PubMed ID: 11867114
    [TBL] [Abstract][Full Text] [Related]  

  • 5. New onset systemic lupus erythematosus in a patient receiving etanercept for rheumatoid arthritis.
    Cairns AP; Duncan MK; Hinder AE; Taggart AJ
    Ann Rheum Dis; 2002 Nov; 61(11):1031-2. PubMed ID: 12379532
    [No Abstract]   [Full Text] [Related]  

  • 6. Anti-TNF-alpha-induced systemic lupus syndrome.
    Debandt M; Vittecoq O; Descamps V; Le Loët X; Meyer O
    Clin Rheumatol; 2003 Feb; 22(1):56-61. PubMed ID: 12605321
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Systemic lupus erythematosus induced by anti-tumour necrosis factor alpha therapy: a French national survey.
    De Bandt M; Sibilia J; Le Loët X; Prouzeau S; Fautrel B; Marcelli C; Boucquillard E; Siame JL; Mariette X;
    Arthritis Res Ther; 2005; 7(3):R545-51. PubMed ID: 15899041
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antinuclear Antibodies and Lupus-like Manifestations in Rheumatoid Arthritis and Ankylosing Spondylitis Patients at 4 Months' Follow-up After Treatment with Infliximab and Etanercept.
    Aghdashi MA; Khadir M; Dinparasti-Saleh R
    Curr Rheumatol Rev; 2020; 16(1):61-66. PubMed ID: 31057111
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Etanercept Immunex.
    Yung RL
    Curr Opin Investig Drugs; 2001 Feb; 2(2):216-21. PubMed ID: 11816834
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Systemic lupus erythematosus in a patient treated with etanercept for polyarticular juvenile rheumatoid arthritis.
    Bout-Tabaku S; Rivas-Chacon R; Restrepo R
    J Rheumatol; 2007 Dec; 34(12):2503-4. PubMed ID: 18061971
    [No Abstract]   [Full Text] [Related]  

  • 11. Etanercept-induced lupus-like syndrome in a patient with rheumatoid arthritis.
    Carlson E; Rothfield N
    Arthritis Rheum; 2003 Apr; 48(4):1165-6; author reply 1166. PubMed ID: 12687569
    [No Abstract]   [Full Text] [Related]  

  • 12. Drug-induced systemic lupus erythematosus associated with etanercept therapy in a child with juvenile idiopathic arthritis.
    Lepore L; Marchetti F; Facchini S; Leone V; Ventura A
    Clin Exp Rheumatol; 2003; 21(2):276-7. PubMed ID: 12747299
    [No Abstract]   [Full Text] [Related]  

  • 13. The clinical application of etanercept in Chinese patients with rheumatic diseases.
    Chou CT
    Mod Rheumatol; 2006; 16(4):206-13. PubMed ID: 16906369
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Lupus like syndrome induced by treatment with anti TNFalpha (infliximab): report of three cases].
    Benucci M; Nenci G; Cappelletti C; Manfredi M
    Recenti Prog Med; 2008; 99(7-8):363-6. PubMed ID: 18751615
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Etanercept-associated SLE with lupus nephritis.
    Neradová A; Stam F; van den Berg JG; Bax WA
    Lupus; 2009 Jun; 18(7):667-8. PubMed ID: 19433471
    [No Abstract]   [Full Text] [Related]  

  • 16. Etanercept-induced pleuropericardial lupus-like syndrome.
    Porfyridis I; Kalomenidis I; Psallidas I; Stratakos G; Roussos C; Vassilakopoulos T; Stathopoulos GT
    Eur Respir J; 2009 Apr; 33(4):939-41. PubMed ID: 19336597
    [No Abstract]   [Full Text] [Related]  

  • 17. Drug-induced systemic lupus erythematosus and TNF-alpha blockers.
    Ferraccioli GF; Assaloni R; Perin A
    Lancet; 2002 Aug; 360(9333):645; author reply 646. PubMed ID: 12241963
    [No Abstract]   [Full Text] [Related]  

  • 18. Drug-induced lupus in anti-TNF-alpha therapy and its treatment with rituximab.
    Diaz JC; Vallejo S; Cañas CA
    Rheumatol Int; 2012 Oct; 32(10):3315-7. PubMed ID: 21881980
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Development of systemic lupus erythematosus with focal proliferative lupus nephritis during anti-TNF-alpha therapy for psoriatic arthritis].
    Haake H; Köneke J; Amann K; vom Dahl J; Janssen U
    Med Klin (Munich); 2007 Oct; 102(10):852-7. PubMed ID: 17928969
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Etanercept-induced subacute cutaneous lupus erythematosus.
    Bleumink GS; ter Borg EJ; Ramselaar CG; Stricker BH
    Rheumatology (Oxford); 2001 Nov; 40(11):1317-9. PubMed ID: 11709621
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.